Global Medtech Guidance Tracker: January 2022
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-eight documents have been posted on the tracker since its last update.
You may also be interested in...
FDA Encourages Voluntary Device Shortage Reporting After PHE End
The FDA updated its policies regarding 506J notifications for device manufacturers at the end of the public health emergency.
IVDR Clinical Evidence: EU Guidance Document Spells Out What Is Required
The long-awaited guidance on how to collect and maintain clinical evidence for diagnostic tests under the IVDR has now been published. It reflects the need for a lifecycle approach to device development and regulation.
2 Become 1: FDA Takes Trip Down Combo Products Premarket Pathway In New Guidance
The 28 January guidance from the US FDA explains the premarket and submission process for combination products and offers tips to manufacturers as they consider which of the agency’s lead centers should review their product.